Applied precision cancer medicine in advanced biliary tract cancer

Bookmark and Share
Published: 15 Jul 2019
Views: 412
Dr Hossein Taghizadeh - Medical University of Vienna, Vienna, Austria

Dr Hossein Taghizadeh speaks to ecancer at ESMO 21st World Congress on Gastrointestinal Cancer about applied precision cancer medicine in advanced therapy-refractory biliary tract cancers (BTC).

He explains that they used real-world data to detect possible targetable genomic mutations that may be used for tailored and targeted therapy.

Dr Taghizadeh concludes that the study showed that precision cancer medicine has the potential for being used to determine treatment options for patients with BTC.


  • Categories: